United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43066-048_654319ae-e5f9-4a6a-b566-201923153b6e
- Product NDC
- 43066-048
- Form
- INJECTION
- Composition / generic term
- Docetaxel
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251127
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL ANHYDROUS — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (43066-048-16) / 16 mL in 1 VIAL, MULTI-DOSE (43066-048-01) · 43066-048-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →